FDA NEWS

UPDATE 1-SuperGen drug fails trial; likely delay to European nod - Reuters
BANGALORE, July 1 (Reuters) - SuperGen Inc (SUPG.O: Quote , Profile , Research , Stock Buzz ) said preliminary efficacy data from a late-stage trial of its blood-disorder treatment failed to meet its main goal, potentially delaying European approval
Source: www.reuters.com

Labopharm Receives Response from FDA Regarding its Once-Daily Tramadol - Forbes
LAVAL, QC, June 30 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that the Company has received a response from the U.S. Food and Drug Administration (FDA) regarding its most recent appeal of the decision in the
Source: www.forbes.com

Halozyme shares rise as drug meets study goal - Forbes
Shares of Halozyme Therapeutics Inc. rose Tuesday after the biotechnology company said its Chemophase drug candidate met safety and tolerability goals in an early-to-midstage study. The stock rose 45 cents, or 8.4 percent, to $5.83 Tuesday. Shares
Source: www.forbes.com

UPDATE 1-FDA denies Labopharm's appeal, requests analysis - Reuters
TORONTO, June 30 (Reuters) - Labopharm Inc (DDS.TO: Quote , Profile , Research , Stock Buzz ) said on Monday that the U.S. Food and Drug Administration has denied the company's appeal of the regulator's decision on its once-daily pain formula
Source: www.reuters.com

Judge sets separate trials on drug, fraud charges against Broadcom co - Minneapolis Star Tribune
Citibank ATM breach reveals PIN security problems Bayreuth's Wagner festival will offer opera online Keeping a landline number on your cell phone Monster founder sets sights on online obituaries Buffett is amazed his lunch drew a $2.1M bid SANTA ANA
Source: www.startribune.com

UPDATE: Teva, After FDA OK, Launches Generic Risperdal - CNN Money
NEW YORK -(Dow Jones)- Teva Pharmaceutical Industries Ltd. (TEVA) received U.S. Food and Drug Administration approval for its generic version of blockbuster schizophrenia treatment Risperdal, developed by Johnson & Johnson ( JNJ) unit Janssen
Source: money.cnn.com

Top Cardiologist Urges FDA To Raise Diabetes Drug Standards - CNN Money
SILVER SPRING, Md. -(Dow Jones)- A prominent medical expert on Tuesday urged the Food and Drug Administration to raise its standards for approving diabetes drugs, saying new drugs need to prove they don't increase cardiovascular disease, the leading
Source: money.cnn.com

UPDATE:Top Expert Urges FDA To Raise Diabetes-Drug Standards - CNN Money
SILVER SPRING, Md. -(Dow Jones)- A prominent medical expert on Tuesday urged the U.S. Food and Drug Administration to raise its standards for approving diabetes drugs, saying companies need to prove new drugs don't increase cardiovascular disease
Source: money.cnn.com